National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 1412173

History of Changes from the VAERS Wayback Machine

First Appeared on 7/23/2021

VAERS ID: 1412173
VAERS Form:2
Age:54.0
Sex:Female
Location:Foreign
Vaccinated:2021-06-03
Onset:2021-06-04
Submitted:0000-00-00
Entered:2021-06-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FA5833 / 1 LA / -

Administered by: Other      Purchased by: ??
Symptoms: Asthenia, Dizziness, Dysarthria, Dyspnoea, Influenza like illness, Mental impairment, Pain, Pain of skin, Pollakiuria

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: VENTOLINE [SALBUTAMOL]; ALVEDON; DUORESP SPIROMAX
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Asthma
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': SEPFIZER INC2021656230

Write-up: urinated 10 times during the night; One day later, the side effects are like the flu; "gone in my head", misspelled when I wrote the first day; Difficulty breathing; dizziness; weak; pain in whole body including skin; pain in whole body including skin; Slurred speech; This is a spontaneous report from a contactable consumer (patient). A 54-years-old female patient received bnt162b2 (COMIRNATY), dose 1 administered in Arm Left on 03Jun2021 01:45 (Lot Number: FA5833) at the age of 54-years-old as single dose for covid-19 immunisation. Medical history included asthma. The patient had no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the covid-19 vaccine, has not been diagnosed with covid-19 prior vaccination. Patient was not pregnant, not pregnant at time of vaccination. Concomitant medications included salbutamol (VENTOLINE); paracetamol (ALVEDON); budesonide, formoterol fumarate (DUORESP SPIROMAX). The patient experienced difficulty breathing, dizziness, weak, pain in whole body including skin; ''gone in my head'', misspelled when wrote the first day, and slurred speech, all above on 04Jun2021 11:00. The patient took paracetamol (ALVEDON) and slept for 3 hours. The adverse events decreased a bit during the evening. The patient also urinated 10 times during the night of 05Jun2021 (no treatment received), one day later on 05Jun2021, the side effects were like the flu (no treatment received). All events were reported as non-serious by the consumer. Patient had not been tested for covid-19 post-vaccination. The outcome of the events was recovering. Follow-up attempts completed. No Further information expected.

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=1412173&WAYBACKHISTORY=ON

Government Disclaimer on use of this data


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166